-
ProCHO® 5 Protein-free CHO Medium Powder kit, 500 LCatalog #: BE15-766L
ProCHO® 5 Protein-free CHO Medium Powder kit with HEPES and 0.1% Pluronic® F-68, without L-Glutamine, phenol red, hypoxanthine or thymidine, 500 L (NAO)
Sales unit: kit -
ProCHO® 5 Protein-free CHO Medium, NAO, Powder Kit w/o PR, 50LCatalog #: BE15-766F
ProCHO® 5, protein free CHO medium, with HEPES and 0.1% Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine, 50L powder kit (NAO)
Sales unit: kit -
ProCHO® 5 Protein-free CHO Medium NAO, Powder kit w/o PR 10 LCatalog #: BE15-766D
ProCHO® 5, protein free CHO medium, with HEPES and 0.1% Pluronic® F-68, without L-Glutamine, phenol red, hypoxanthine or thymidine, 10 L powder kit (NAO)
Sales unit: kit -
ProCHO® 5 Protein-free CHO Medium NAO, Basal Powder, w/o PR 50 LCatalog #: WPW-045F
ProCHO® 5 Protein-free CHO Medium, basal powder, 50 L (NAO)
Sales unit: pail -
ProCHO® 5 Protein-free CHO Medium NAO, Basal Powder, w/o PR 500 LCatalog #: WPW-045L
ProCHO® 5 Protein-free CHO Medium, basal powder, 500 L (NAO)
Sales unit: pail -
ProCHO® 5 Protein-free CHO Medium, 1LCatalog #: BELN12-766Q
ProCHO® 5 protein free CHO medium, with HEPES and 0.1% Pluronic® F-68, without L-Glutamine, phenol red, hypoxanthine or thymidine, 1 L (NAO)
Sales unit: each -
ProCHO® 4 Protein-free CHO Medium, 1LCatalog #: 04-919Q
ProCHO® 4 Protein-free CHO Medium with 0.1% Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine, 1 L.
Sales unit: each -
ProCHO® 4 Protein-free CHO Medium, 1LCatalog #: BP04-919Q
ProCHO® 4 Protein-free CHO Medium with 0.1% Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine, 1 L
Sales unit: Bottle -
Pro293TMa Serum-free Medium – Chemically Defined for 293 Adherent CellsCatalog #: BEBP12-764Q
Pro293TMa Serum-free Medium, chemically defined for adherent cells, without L-glutamine or phenol red with 0.1% Pluronic® F-68, 1 L
Sales unit: each -
Pro293s™ Serum-free Medium – Chemically Defined for 293 Cells in SuspensionCatalog #: BEBP02-025Q
Pro293sTM Serum-free Medium, chemically defined, for suspension cells, without L-glutamine, phenol red, galactose or Pluronic® F-68, 1 L
Sales unit: each
-
Inducible Cas9 T Cells: An Innovative Platform for Allogeneic CAR-T Cell GenerationPoster on inducible Cas9 T Cells
-
Synthego_Lonza_Protocol_Genome Editing of Resting T cellsTechnical Protocol on Genome Editing of Resting T cells for associated White Paper "Genome Editing of Resting T cells"
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
-
PBMC Based T Cell Proliferation AssayProtocol instructions
-
Instructions for Use – TheraPEAK® T-VIVO® Cell Culture Medium for Gamma Delta (γδ) T CellsInstructions for how to culture gamma delta (γδ) T Cells using TheraPEAK® T-VIVO® Cell Culture Medium
-
Instructions for Use - Dendritic Cell (DC) and T Cell Assay from Matched PBMCsProtocol for DC and T Cell Assay from Matched PBMCs
-
Large-scale editing of human T cells
-
Case Study – Improving the Expansion of Patients' T CellsIn this serum-free media case study, learn how selection of memory T cells can aid in streamlining CAR-T therapies.
-
Synthego-Lonza Genome Editing of Resting T cellsCase Study on Genome Editing of Resting T cells
-
A Novel Chemically Defined Medium Supports Superior Cross-platform T-cell ExpansionThis poster showcases how the chemically defined TheraPEAK® T-VIVO® Medium supports superior T-cell expansion across different platforms.